
You can purchase shares of LeonaBio (NASDAQ:LONA) through any online brokerage.
Other companies in LeonaBio’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
LeonaBio has a consensus price target of $17.00.
The stock price for LeonaBio (NASDAQ: LONA) is $3.1476 last updated November 13, 2026 at 7:21 PM EST.
There are no upcoming dividends for LeonaBio.
LeonaBio does not have any upcoming earnings scheduled.
There is no upcoming split for LeonaBio.
LeonaBio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to...